Reprint of "The clinical impact of deficiency in DNA non-homologous end-joining"

DNA Repair

Volumn 17, Issue , 2014, Pages 9-20

  Woodbine, Lisa ^a   Gennery, Andrew R ^b   Jeggo, Penny A ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

(Severe) combined immunodeficiency (S)CID; Double strand break repair; Human syndromes; Mammalian cells; V(D)J recombination

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DNA LIGASE IV; DOUBLE STRANDED DNA; HETERODIMER; KU ANTIGEN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN; UNCLASSIFIED DRUG; XLF PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; DNA BINDING; DNA END JOINING REPAIR; DOUBLE STRANDED DNA BREAK; GENE MUTATION; GROWTH DISORDER; HUMAN; IMMUNE RESPONSE; LIG4 SYNDROME; MICROCEPHALY; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; SQUAMOUS CELL CARCINOMA;

EID: 84900450280     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.04.002     Document Type: Article

References (114)

1. Wang C., Lees-Miller S.P. Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining. International Journal of Radiation Oncology, Biology and Physics 2013, 86:440-449.
2. van Gent D.C., van der Burg M. Non-homologous end-joining, a sticky affair. Oncogene 2007, 26:7731-7740.
3. Goodarzi A.A., Jeggo P.A. The repair and signaling responses to DNA double-strand breaks. Advances in Genetics 2013, 82:1-45.
4. Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 1995, 82:849-856.
5. Paillard S., Strauss F. Analysis of the mechanism of interaction of simian Ku protein with DNA. Nucleic Acids Research 1991, 19:5619-5624.
6. Britton S., Coates J., Jackson S.P. A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair. Journal of Cell Biology 2013, 202:579-595.
7. Gottlieb T.M., Jackson S.P. The DNA-dependent protein kinase: requirement of DNA ends and association with Ku Antigen. Cell 1993, 72:131-142.
8. Walker J.R., Corpina R.A., Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 2001, 412:607-614.
9. Sibanda B.L., Chirgadze D.Y., Blundell T.L. Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats. Nature 2010, 463:118-121.
10. Hammel M., Yu Y., Mahaney B.L., Cai B., Ye R., Phipps B.M., Rambo R.P., Hura G.L., Pelikan M., So S., Abolfath R.M., Chen D.J., Lees-Miller S.P., Tainer J.A. Ku and DNA-dependent protein kinase dynamic conformations and assembly regulate DNA binding and the initial non-homologous end joining complex. Journal of Biological Chemistry 2010, 285:1414-1423.
11. Meek K., Douglas P., Cui X., Ding Q., Lees-Miller S.P. trans-Autophosphorylation at DNA-dependent protein kinase's two major autophosphorylation site clusters facilitates end processing but not end joining. Molecular and Cellular Biology 2007, 27:3881-3890.
12. Zolner A.E., Abdou I., Ye R., Mani R.S., Fanta M., Yu Y., Douglas P., Tahbaz N., Fang S., Dobbs T., Wang C., Morrice N., Hendzel M.J., Weinfeld M., Lees-Miller S.P. Phosphorylation of polynucleotide kinase/phosphatase by DNA-dependent protein kinase and ataxia-telangiectasia mutated regulates its association with sites of DNA damage. Nucleic Acids Research 2011, 39:9224-9237.
13. Ma Y., Pannicke U., Schwarz K., Lieber M.R. Hairpin opening and overhang processing by an artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 2002, 108:781-794.
14. Pannicke U., Ma Y., Hopfner K.P., Niewolik D., Lieber M.R., Schwarz K. Functional and biochemical dissection of the structure-specific nuclease ARTEMIS. EMBO Journal 2004, 23:1987-1997.
15. Riballo E., Kuhne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Molecular Cell 2004, 16:715-724.
16. Krempler A., Deckbar D., Jeggo P.A., Lobrich M. An imperfect G(2)/M checkpoint contributes to chromosome instability following irradiation of S and G(2) phase cells. Cell Cycle 2007, 6:1682-1686.
17. Shibata A., Conrad S., Birraux J., Geuting V., Barton O., Ismail A., Kakarougkas A., Meek K., Taucher-Scholz G., Lobrich M., Jeggo P.A. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO Journal 2011, 30:1079-1092.
18. Goodarzi A.A., Yu Y., Riballo E., Douglas P., Walker S.A., Ye R., Harer C., Marchetti C., Morrice N., Jeggo P.A., Lees-Miller S.P. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. EMBO Journal 2006, 25:3880-3889.
19. Drouet J., Delteil C., Lefrancois J., Concannon P., Salles B., Calsou P. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. Journal Biological Chemistry 2005, 280:7060-7069.
20. Cottarel J., Frit P., Bombarde O., Salles B., Negrel A., Bernard S., Jeggo P.A., Lieber M.R., Modesti M., Calsou P. A noncatalytic function of the ligation complex during nonhomologous end joining. Journal of Cell Biology 2013, 200:173-186.
21. Merkle D., Douglas P., Moorhead G.B., Leonenko Z., Yu Y., Cramb D., Bazett-Jones D.P., Lees-Miller S.P. The DNA-dependent protein kinase interacts with DNA to form a protein-DNA complex that is disrupted by phosphorylation. Biochemistry 2002, 41:12706-12714.
22. Feng L., Chen J. The E3 ligase RNF8 regulates KU80 removal and NHEJ repair. Nature Structural and Molecular Biology 2012, 19:201-206.
23. Wei Y.-F., Robins P., Carter K., Caldecott K., Pappin D.J.C., Yu G.-L., Wang R.-P., Shell B.K., Nash R.A., Scar P., Barnes D.E., Haseltine W.A., Lindahl T. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Molecular and Cellular Biology 1995, 15:3206-3216.
24. Tomkinson A.E., Mackey Z.B. Structure and function of mammalian DNA ligases. Mutation Research 1998, 407:1-9.
25. Sibanda B.L., Critchlow S.E., Begun J., Pei X.Y., Jackson S.P., Blundell T.L., Pellegrini L. Crystal structure of an Xrcc4-DNA ligase IV complex. Nature Structural Biology 2001, 8:1015-1019.
26. Grawunder U., Zimmer D., Lieber M.R. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Current Biology 1998, 8:873-876.
27. Wu P.Y., Frit P., Meesala S., Dauvillier S., Modesti M., Andres S.N., Huang Y., Sekiguchi J., Calsou P., Salles B., Junop M.S. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4. Molecular and Cellular Biology 2009, 29:3163-3172.
28. Critchlow S.E., Bowater R.P., Jackson S.P. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Current Biology 1997, 7:588-598.
29. Grawunder U., Zimmer D., Kulesza P., Lieber M. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. Journal of Biological Chemistry 1998, 73:24708-24714.
30. Riballo E., Woodbine L., Stiff T., Walker S.A., Goodarzi A.A., Jeggo P.A. XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation. Nucleic Acids Research 2009, 37:482-492.
31. Ahnesorg P., Smith P., Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006, 124:301-313.
32. Li Y., Chirgadze D.Y., Bolanos-Garcia V.M., Sibanda B.L., Davies O.R., Ahnesorg P., Jackson S.P., Blundell T.L. Crystal structure of human XLF/Cernunnos reveals unexpected differences from XRCC4 with implications for NHEJ. EMBO Journal 2008, 27:290-300.
33. Andres S.N., Vergnes A., Ristic D., Wyman C., Modesti M., Junop M. A human XRCC4-XLF complex bridges DNA. Nucleic Acids Research 2012, 40:1868-1878.
34. Mahaney B.L., Hammel M., Meek K., Tainer J.A., Lees-Miller S.P. XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair. Biochemistry and Cellular Biology 2013, 91:31-41.
35. Tsai C.J., Chu G. Cooperative assembly of a protein-DNA filament for nonhomologous end joining. Journal of Biological Chemistry 2013, 288:18110-18120.
36. Alt F.W., Zhang Y., Meng F.L., Guo C., Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 2013, 152:417-429.
37. Bednarski J.J., Sleckman B.P. Lymphocyte development: integration of DNA damage response signaling. Advances in Immunology 2012, 116:175-204.
38. Bednarski J.J., Sleckman B.P. Integrated signaling in developing lymphocytes: the role of DNA damage responses. Cell Cycle 2012, 11:4129-4134.
39. O'Driscoll M., Cerosaletti K.M., Girard P.-M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A., Varon R., Oettinger M.A., Sperling K., Jeggo P.A., Concannon P. DNA Ligase IV mutations identified in patients exhibiting development delay and immunodeficiency. Molecular Cell 2001, 8:1175-1185.
40. Barnes D.E., Stamp G., Rosewell I., Denzel A., Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Current Biology 1998, 8:1395-1398.
41. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998, 396:173-177.
42. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998, 95:891-902.
43. Riballo E., Critchlow S.E., Teo S.H., Doherty A.J., Priestley A., Broughton B., Kysela B., Beamish H., Plowman N., Arlett C.F., Lehmann A.R., Jackson S.P., Jeggo P.A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Current Biology 1999, 19:699-702.
44. Plowman P.N., Bridges B.A., Arlett C.F., Hinney A., Kingston J.E. An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. British Journal of Radiology 1990, 63:624-628.
45. Riballo E., Doherty A.J., Dai Y., Stiff T., Oettinger M.A., Jeggo P.A., Kysela B. Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. Journal of Biological Chemistry 2001, 276:31124-31132.
46. van der Burg M., van Veelen L.R., Verkaik N.S., Wiegant W.W., Hartwig N.G., Barendregt B.H., Brugmans L., Raams A., Jaspers N.G., Zdzienicka M.Z., van Dongen J.J., van Gent D.C. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. Journal of Clinical Investigation 2006, 116:137-145.
47. Buck D., Moshous D., de Chasseval R., Ma Y., le Deist F., Cavazzana-Calvo M., Fischer A., Casanova J.L., Lieber M.R., de Villartay J.P. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. European Journal of Immunology 2006, 36:224-235.
48. Grunebaum E., Bates A., Roifman C.M. Omenn syndrome is associated with mutations in DNA ligase IV. Journal of Allergy and Clinical Immunology 2008, 122:1219-1220.
49. Toita N., Hatano N., Ono S., Yamada M., Kobayashi R., Kobayashi I., Kawamura N., Okano M., Satoh A., Nakagawa A., Ohshima K., Shindoh M., Takami T., Kobayashi K., Ariga T. Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. American Journal of Medical Genetics 2007, 143:742-745.
50. Bacon C.M., Wilkinson S.J., Spickett G.P., Barge D., Lucraft H.H., Jackson G., Rand V., Gennery A.R. Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency. Journal of Allergy and Clinical Immunology 2013, 131:1237-1239. 1239 and 1231.
51. Girard P.-M., Kysela B., Harer C.J., Doherty A.J., Jeggo P.A. Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms. Human Molecular Genetics 2004, 13:2369-2376.
52. CavazzanaCalvo M., Le Deist F., De Saint Basile G., Papadopoulo D., De Villartay J.P., Fischer A. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. Journal of Clinical Investigation 1993, 91:1214-1218.
53. Nicolas N., Moshous D., Cavazzana-Calvo M., Papadopoulo D., de Chasseval R., Le Deist F., Fischer A., de Villartay J.P. A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA recombination/repair deficiency. Journal of Experimental Medicine 1998, 188:627-634.
54. Dai Y., Kysela B., Hanakahi L.A., Manolis K., Riballo E., Stumm M., Harville T.O., West S.C., Oettinger M.A., Jeggo P.A. Non-homologous end joining and V(D)J recombination require an additional factor. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2462-2467.
55. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001, 105:177-186.
56. Buck D., Malivert L., de Chasseval R., Barraud A., Fondaneche M.C., Sanal O., Plebani A., Stephan J.L., Hufnagel M., le Deist F., Fischer A., Durandy A., de Villartay J.P., Revy P. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006, 124:287-299.
57. Kegel A., Sjostrand J.O., Astrom S.U. Nej1p, a cell type-specific regulator of nonhomologous end joining in yeast. Current Biology 2001, 11:1611-1617.
58. Callebaut I., Malivert L., Fischer A., Mornon J.P., Revy P., de Villartay J.P. Cernunnos interacts with the XRCC4×DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1. Journal of Biological Chemistry 2006, 281:13857-13860.
59. Hentges P., Ahnesorg P., Pitcher R.S., Bruce C.K., Kysela B., Green A.J., Bianchi J., Wilson T.E., Jackson S.P., Doherty A.J. Evolutionary and functional conservation of the DNA non-homologous end-joining protein, XLF/Cernunnos. Journal of Biological Chemistry 2006, 281:37517-37526.
60. Zha S., Alt F.W., Cheng H.L., Brush J.W., Li G. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4518-4523.
61. Rooney S., Alt F.W., Lombard D., Whitlow S., Eckersdorff M., Fleming J., Fugmann S., Ferguson D.O., Schatz D.G., Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. Journal of Experimental Medicine 2003, 197:553-565.
62. Woodbine L., Brunton H., Goodarzi A.A., Shibata A., Jeggo P.A. Endogenously induced DNA double strand breaks arise in heterochromatic DNA regions and require ataxia telangiectasia mutated and Artemis for their repair. Nucleic Acids Research 2011, 39:6986-6997.
63. Pannicke U., Honig M., Schulze I., Rohr J., Heinz G.A., Braun S., Janz I., Rump E.M., Seidel M.G., Matthes-Martin S., Soerensen J., Greil J., Stachel D.K., Belohradsky B.H., Albert M.H., Schulz A., Ehl S., Friedrich W., Schwarz K. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events. Human Mutation 2010, 31:197-207.
64. de Villartay J.P. V(D)J recombination deficiencies. Advances in Experimental Medicine and Biology 2009, 650:46-58.
65. Dvorak C.C., Cowan M.J. Radiosensitive severe combined immunodeficiency disease. Immunology and Allergy Clinics of North America 2010, 30:125-142.
66. Felgentreff K., Perez-Becker R., Speckmann C., Schwarz K., Kalwak K., Markelj G., Avcin T., Qasim W., Davies E.G., Niehues T., Ehl S. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clinical Immunology 2011, 141:73-82.
67. Lee P.P., Woodbine L., Gilmour K.C., Bibi S., Cale C.M., Amrolia P.J., Veys P.A., Davies E.G., Jeggo P.A., Jones A. The many faces of Artemis-deficient combined immunodeficiency - two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation. Clinical Immunology 2013, 149:464-474.
68. Ege M., Ma Y., Manfras B., Kalwak K., Lu H., Lieber M.R., Schwarz K., Pannicke U. Omenn syndrome due to ARTEMIS mutations. Blood 2005, 105:4179-4186.
69. Moshous D., Pannetier C., Chasseval Rd R., Deist Fl F., Cavazzana-Calvo M., Romana S., Macintyre E., Canioni D., Brousse N., Fischer A., Casanova J.L., Villartay J.P. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. Journal of Clinical Investigation 2003, 111:381-387.
70. Jacobs C., Huang Y., Masud T., Lu W., Westfield G., Giblin W., Sekiguchi J.M. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis. Human Molecular Genetics 2011, 20:806-819.
71. de Villartay J.P. V(D)J recombination and DNA repair: lessons from human immune deficiencies and other animal models. Current Opinion in Allergy and Clinical Immunology 2002, 2:473-479.
72. Woodbine L., Grigoriadou S., Goodarzi A.A., Riballo E., Tape C., Oliver A.W., van Zelm M.C., Buckland M.S., Davies E.G., Pearl L.H., Jeggo P.A. An Artemis polymorphic variant reduces Artemis activity and confers cellular radiosensitivity. DNA Repair (Amsterdam) 2010, 9:1003-1010.
73. Bosma M.J., Carroll A.M. The SCID mouse mutant: definition, characterization, and potential uses. Annual Reviews in Immunology 1991, 9:323-350.
74. Blunt T., Finnie N.J., Taccioli G.E., Smith G.C.M., Demengeot J., Gottlieb T.M., Mizuta R., Varghese A.J., Alt F.W., Jeggo P.A., Jackson S.P. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995, 80:813-823.
75. van der Burg M., Ijspeert H., Verkaik N.S., Turul T., Wiegant W.W., Morotomi-Yano K., Mari P.O., Tezcan I., Chen D.J., Zdzienicka M.Z., van Dongen J.J., van Gent D.C. A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. Journal of Clinical Investigation 2009, 119:91-98.
76. Fattah K.R., Ruis B.L., Hendrickson E.A. Mutations to Ku reveal differences in human somatic cell lines. DNA Repair (Amsterdam) 2008, 7:762-774.
77. Wang Y., Ghosh G., Hendrickson E.A. Ku86 represses lethal telomere deletion events in human somatic cells. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12430-12435.
78. Ruis B.L., Fattah K.R., Hendrickson E.A. The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells. Molecular and Cellular Biology 2008, 28:6182-6195.
79. Woodbine L., Neal J.A., Sasi N.K., Shimada M., Deem K., Coleman H., Dobyns W.B., Ogi T., Meek K., Davies E.G., Jeggo P.A. PRKDC mutations in a SCID patient with profound neurological abnormalities. Journal of Clinical Investigation 2013, 123:2969-2980.
80. Taylor A.M., Groom A., Byrd P.J. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amsterdam) 2004, 3:1219-1225.
81. Ambrose M., Gatti R.A. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 2013, 121:4036-4045.
82. International Nijmegen Breakage Syndrome Study Group Nijmegen breakage syndrome. The International Nijmegen Breakage Syndrome Study Group. Archives of Disease in Childhood 2000, 82:400-406.
83. Waltes R., Kalb R., Gatei M., Kijas A.W., Stumm M., Sobeck A., Wieland B., Varon R., Lerenthal Y., Lavin M.F., Schindler D., Dork T. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. American Journal of Human Genetics 2009, 84:605-616.
84. Jeggo P., Lavin M.F. Cellular radiosensitivity: how much better do we understand it?. International Journal of Radiation Biology 2009, 85:1061-1081.
85. Bowen S., Wangsa D., Ried T., Livak F., Hodes R.J. Concurrent V(D)J recombination and DNA end instability increase interchromosomal trans-rearrangements in ATM-deficient thymocytes. Nucleic Acids Research 2013, 41:4535-4548.
86. Lahdesmaki A., Taylor A.M., Chrzanowska K.H., Pan-Hammarstrom Q. Delineation of the role of the Mre11 complex in class switch recombination. Journal of Biological Chemistry 2004, 279:16479-16487.
87. Matsumoto Y., Miyamoto T., Sakamoto H., Izumi H., Nakazawa Y., Ogi T., Tahara H., Oku S., Hiramoto A., Shiiki T., Fujisawa Y., Ohashi H., Sakemi Y., Matsuura S. Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly. DNA Repair (Amsterdam) 2011, 10:314-321.
88. Rucci F., Notarangelo L.D., Fazeli A., Patrizi L., Hickernell T., Paganini T., Coakley K.M., Detre C., Keszei M., Walter J.E., Feldman L., Cheng H.L., Poliani P.L., Wang J.H., Balter B.B., Recher M., Andersson E.M., Zha S., Giliani S., Terhorst C., Alt F.W., Yan C.T. Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3024-3029.
89. Nijnik A., Dawson S., Crockford T.L., Woodbine L., Visetnoi S., Bennett S., Jones M., Turner G.D., Jeggo P.A., Goodnow C.C., Cornall R.J. Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. Journal of Clinical Investigation 2009, 119:1696-1705.
90. Nijnik A., Woodbine L., Marchetti C., Dawson S., Lambe T., Liu C., Rodrigues N.P., Crockford T.L., Cabuy E., Vindigni A., Enver T., Bell J.I., Slijepcevic P., Goodnow C.C., Jeggo P.A., Cornall R.J. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007, 447:686-690.
91. Pontious A., Kowalczyk T., Englund C., Hevner R.F. Role of intermediate progenitor cells in cerebral cortex development. Developmental Neuroscience 2008, 30:24-32.
92. Mitsuhashi T., Takahashi T. Genetic regulation of proliferation/differentiation characteristics of neural progenitor cells in the developing neocortex. Brain and Development 2009, 31:553-557.
93. Egger B., Gold K.S., Brand A.H. Regulating the balance between symmetric and asymmetric stem cell division in the developing brain. Fly (Austin) 2011, 5:237-241.
94. Thornton G.K., Woods C.G. Primary microcephaly: do all roads lead to Rome?. Trends in Genetics 2009, 25:501-510.
95. Gatz S.A., Ju L., Gruber R., Hoffmann E., Carr A.M., Wang Z.Q., Liu C., Jeggo P.A. Requirement for DNA ligase IV during embryonic neuronal development. Journal of Neuroscience 2011, 31:10088-10100.
96. McKinnon P.J., Caldecott K.W. DNA strand break repair and human genetic disease. Annual Reviews in Genomics and Human Genetics 2007, 8:37-55.
97. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Molecular Cell 2000, 5:993-1002.
98. O'Driscoll M., Gennery A.R., Seidel J., Concannon P., Jeggo P.A. An overview of three disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amsterdam) 2004, 3:1227-1235.
99. O'Driscoll M., Jeggo P.A. CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair. Bone Marrow Transplantation 2008, 41:983-989.
100. Gruhn B., Seidel J., Zintl F., Varon R., Tonnies H., Neitzel H., Bechtold A., Hoehn H., Schindler D. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet Journal of Rare Diseases 2007, 2:5.
101. O'Marcaigh A.S., DeSantes K., Hu D., Pabst H., Horn B., Li L., Cowan M.J. Bone marrow transplantation for T-B-severe combined immunodeficiency disease in Athabascan-speaking native Americans. Bone Marrow Transplantation 2001, 27:703-709.
102. Chase N.M., Verbsky J.W., Routes J.M. Newborn screening for SCID: three years of experience. Annals of the New York Academy of Sciences 2011, 1238:99-105.
103. Martin O.A., Ivashkevich A., Choo S., Woodbine L., Jeggo P.A., Martin R.F., Lobachevsky P. Statistical analysis of kinetics, distribution and co-localisation of DNA repair foci in irradiated cells: cell cycle effect and implications for prediction of radiosensitivity. DNA Repair (Amsterdam) 2013, 12:844-855.
104. Yue J., Lu H., Lan S., Liu J., Stein M.N., Haffty B.G., Shen Z. Identification of the DNA repair defects in a case of Dubowitz syndrome. PLOS ONE 2013, 8:e54389.
105. Enders A., Fisch P., Schwarz K., Duffner U., Pannicke U., Nikolopoulos E., Peters A., Orlowska-Volk M., Schindler D., Friedrich W., Selle B., Niemeyer C., Ehl S. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. Journal of Immunology 2006, 176:5060-5068.
106. Cantagrel V., Lossi A.M., Lisgo S., Missirian C., Borges A., Philip N., Fernandez C., Cardoso C., Figarella-Branger D., Moncla A., Lindsay S., Dobyns W.B., Villard L. Truncation of NHEJ1 in a patient with polymicrogyria. Human Mutation 2007, 28:356-364.
107. Dutrannoy V., Demuth I., Baumann U., Schindler D., Konrat K., Neitzel H., Gillessen-Kaesbach G., Radszewski J., Rothe S., Schellenberger M.T., Nurnberg G., Nurnberg P., Teik K.W., Nallusamy R., Reis A., Sperling K., Digweed M., Varon R. Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Human Mutation 2010, 31:1059-1068.
108. Faraci M., Lanino E., Micalizzi C., Morreale G., Di Martino D., Banov L., Comoli P., Locatelli F., Soresina A., Plebani A. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency. Pediatric Transplantation 2009, 13:785-789.
109. Turul T., Tezcan I., Sanal O. Cernunnos deficiency: a case report. Journal of Investigational Allergology and Clinical Immunolology 2011, 21:313-316.
110. Peake J., Waugh A., LeDeist F., Priestley A., Rieux-Laucat F., Foray N., Capulas E., Singleton B.K., deVillartay J.-P., Cant A., Malaise E.P., Fischer A., Hivroz C., Jeggo P.A. Combined immunodeficiency associated with increased apoptosis of lymphocytes and radiosensitivity of fibroblasts. Cancer Research 1999, 59:3454-3460.
111. Evans P.M., Woodbine L., Riballo E., Gennery A.R., Hubank M., Jeggo P.A. Radiation-induced delayed cell death in a hypomorphic Artemis cell line. Human and Molecular Genetics 2006, 15:1303-1311.
112. Rohr J., Pannicke U., Doring M., Schmitt-Graeff A., Wiech E., Busch A., Speckmann C., Muller I., Lang P., Handgretinger R., Fisch P., Schwarz K., Ehl S. Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency. Journal of Clinical Immunology 2010, 30:314-320.
113. Ijspeert H., Lankester A.C., van den Berg J.M., Wiegant W., van Zelm M.C., Weemaes C.M., Warris A., Pan-Hammarstrom Q., Pastink A., van Tol M.J., van Dongen J.J., van Gent D.C., van der Burg M. Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide. Genes and Immunity 2011, 12:434-444.
114. Bajin I.Y., Ayvaz D.C., Unal S., Ozgur T.T., Cetin M., Gumruk F., Tezcan I., de Villartay J.P., Sanal O. Atypical combined immunodeficiency due to Artemis defect: a case presenting as hyperimmunoglobulin M syndrome and with LGLL. Molecular Immunology 2013, 56:354-357.